Signaling flux redistribution at toll-like receptor pathway junctions

PLoS ONE

Volumn 3, Issue 10, 2008, Pages

  Selvarajoo, Kumar ^a   Takada, Yasunari ^a   Gohda, Jin ^b   Helmy, Mohamed ^a   Akira, Shizuo ^c   Tomita, Masaru ^a   Tsuchiya, Masa ^a   Inoue, Jun Ichiro ^b   Matsuo, Koichi ^a  

^a KEIO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON REGULATORY FACTOR 3; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN LFIT2; PROTEIN RIP1; PROTEIN TBK1; PROTEIN TRAM; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG; INTERLEUKIN RECEPTOR; IRF3 PROTEIN, MOUSE; MYD88 PROTEIN, MOUSE; TIRP PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MACROPHAGE; MOUSE; NONHUMAN; PLASMID; PREDICTION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; BIOLOGY; CELL CULTURE; GENETIC TRANSFECTION; GENETICS; METABOLISM; MOUSE MUTANT;

ANIMALS; CELLS, CULTURED; COMPUTATIONAL BIOLOGY; HUMANS; INTERFERON REGULATORY FACTOR-3; MICE; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; RECEPTORS, INTERLEUKIN; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 6; TOLL-LIKE RECEPTOR 4; TRANSFECTION;

EID: 55349098506     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003430     Document Type: Article

References (32)

1. Carpenter S, O'Neill LA (2007) How important are Toll-like receptors for antimicrobial responses? Cell Microbiol 9: 1891-1901.
2. Kawai T, Akira S (2007) TLR signaling. Semin Immunol 19: 24-32.
3. Yamamoto M, Sato S, Hemmi H, Uematsu S, Hoshino K, et al. (2003) TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol 4: 1144-1150.
4. Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4: 499-511.
5. Gohda J, Matsumura T, Inoue J (2004) Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not toll/ IL-1 receptor domain-containing adaptor-inducing IFN-β (TRIF)-dependent pathway in TLR signaling. J Immunol 173: 2913-2917.
6. Hirotani T, Yamamoto M, Kumagai Y, Uemarsu S, Kawase I, et al. (2005) Regulation of lipopolysaccharide-inducible genes by MyD88 and Toll/IL-1 domain containing adaptor inducing IFN-β. Biochem Biophys Res Commun 328: 383-392.
7. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S (1999) Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11:115-122.
8. Kawai T, Takeuchi O, Fujita T, Inoue J, Muhlradt PF, et al. (2001) Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol 167: 5887-5894.
9. Selvarajoo K (2006) Discovering differential activation machinery of the Toll-like receptor 4 signaling pathways in MyD88 knockouts. FEBS Lett 580: 1457-1464.
10. Vance W, Arkin A, Ross J (2002) Determination of causal connectivities of species in reaction networks. Proc Natl Acad Sci U S A 99: 5816-5821.
11. Levine RL, Wadleigh M, Cools J, Ebert BL, Wernig G, et al. (2005) Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 7: 387-397.
12. Pandit B, Sarkozy A, Pennacchio LA, Carta C, Oishi K, et al. (2007) Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat Genet 39: 1007-1012.
13. Smale ST, Fisher AG (2002) Chromatin structure and gene regulation in the immune system. Annu Rev Immunol 20: 427-462.
14. Yeo ZX, Wong ST, Arjunan SN, Piras M, Tomita M, et al. (2007) Sequential logic model deciphers dynamic transcriptional control of gene expressions. PLoS ONE 2: e776.
15. Ross J (2008) Determination of complex reaction mechanisms. Analysis of chemical, biological and genetic networks. J Phys Chem A 112: 2134-2143.
16. Selvarajoo K, Tsuchiya M (2007) Systematic Determination of Biological Network Topology: Non-Integral Connectivity Method (NICM). In Choi S, ed. Introduction to Systems Biology. New Jersey, USA: The Humana Press, Inc. pp 449-471.
17. Ehlting C, Lai WS, Schaper F, Brenndorfer ED, Matthes RJ, et al. (2007) Regulation of suppressor of cytokine signaling 3 (SOCS3) mRNA stability by TNF-α involves activation of the MKK6/p38MAPK/MK2 cascade. J Immunol 178: 2813-2826.
18. Hitti E, Iakovleva T, Brook M, Deppenmeier S, Gruber AD, et al. (2006) Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/ uridine-rich element. Mol Cell Biol 26: 2399-2407.
19. Hui L, Bakiri L, Mairhorfer A, Schweifer N, Haslinger C, et al. (2007) p38-alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway. Nat Genet 39: 741-749.
20. O'Neill LA, Bowie AG (2007) The family of five: TIR-domain-containing adaptors in roll-like receptor signalling. Nat Rev Immunol 7: 353-364.
21. Sato S, Sugiyama M, Yamamoto M, Watanabe Y, Kawai T, et al. (2003) Toll/ IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-κB and IFN-regulatory factor-3, in the Toll-like receptor signalinig. J Immunol 171: 4304-4310.
22. Naito A, Azuma S, Tanaka S, Miyazaki T, Takaki S, et al. (1999) Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells 4: 353-362.
23. Pawson T, Nash P (2003) Assembly of cell regulatory systems through protein interaction domains. Science 300: 445-452.
24. Meylan E, Burns K, Hofmann K, Blancheteau V, Martinon F, et al. (2004) RIP1 is an essential mediator of Toll-like receptor 3-induced NF-κB activation. Nat Immunol 5: 503-507.
25. Kagan JC, Su T, Horng, Chow A, Akira S, et al. (2008) TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β. Nat Immunol 9: 361-368.
26. McGettrick AF, Brint EK, Palsson-McDermott EM, Rowe DC, Golenbock DT, et al. (2006) Trif-related adapter molecule is phosphorylated by PKĊ during Toll-like receptor 4 signaling. Proc Natl Acad Sci U S A 103: 9196-9201.
27. Jin Z, El-Deiry WS (2006) Distinct signaling pathways in TRAIL- versus tumor necrosis factor-induced apoptosis. Mol Cell Biol 26: 8136-8148.
28. Paz K, Hemi R, LeRoith D, Karasik A, Elhanany E, et al. (1997) A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem 272: 29911-29918.
29. Kholodenko BN (2006) Cell-signalling dynamics in time and space. Nat Rev Mol Cell Biol 7: 165-176.
30. Werner SL, Barken D, Hoffmann A (2005) Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science 309: 1857-1861.
31. Takahashi K, Ishikawa N, Sadamoto Y, Sasamoto H, Ohta S, et al. (2003) E-Cell 2: multi-platform E-Cell simulation system. Bioinformatics 19: 1727-1729.
32. Ray N, Kuwahara M, Takada Y, Maruyama K, Kawaguchi T, et al. (2006) c-Fos suppresses systemic inflammatory response to endotoxin. Int Immunol 18: 671-677.